Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

38.57
+0.17000.44%
Post-market: 38.570.00000.00%18:07 EDT
Volume:3.17M
Turnover:122.38M
Market Cap:7.32B
PE:-10.91
High:39.16
Open:38.85
Low:38.12
Close:38.40
Loading ...

BridgeBio Announces CFO Succession

THOMSON REUTERS
·
18 Mar

BridgeBio Pharma Inc - Appoints Thomas Trimarchi as President and CFO

THOMSON REUTERS
·
18 Mar

BridgeBio Pharma Inc - Brian Stephenson to Depart

THOMSON REUTERS
·
18 Mar

Analysts’ Top Healthcare Picks: BridgeBio Pharma (BBIO), Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
11 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)

TIPRANKS
·
11 Mar

Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors

Business Wire
·
10 Mar

J.P. Morgan Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
08 Mar

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
07 Mar

BridgeBio Shares Fall After KKR Genetic Disorder Sells 6 Million Shares

MT Newswires Live
·
06 Mar

KKR Genetic Dosorder L.P. announces sale of 6M shares of BridgeBio

TIPRANKS
·
06 Mar

BridgeBio prices $575M convertible notes offering

TIPRANKS
·
06 Mar

BRIEF-BridgeBio Pharma Issues $575 Million Of 1.75% Convertible Senior Notes Due 2031

Reuters
·
01 Mar

BridgeBio Pharma Inc - Issues $575 Million of 1.75% Convertible Senior Notes Due 2031

THOMSON REUTERS
·
01 Mar

BridgeBio Pharma Inc - Notes Mature on March 1, 2031

THOMSON REUTERS
·
01 Mar

BUZZ-Raymond James resumes coverage on BridgeBio with 'outperform' on heart drug optimism

Reuters
·
01 Mar

Helix Acquisition to Merge With BridgeBio Oncology Therapeutics

MT Newswires Live
·
28 Feb

BridgeBio price target raised to $46 from $45 at BofA

TIPRANKS
·
28 Feb

BridgeBio Pharma (BBIO): Among the Best Performing Mid Cap Stocks to Buy According to Analysts

Insider Monkey
·
27 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Cheesecake Factory, SiriusPoint, Arcutis Biosciences

Reuters
·
27 Feb

BridgeBio Pharma Prices $500 Million Convertible Senior Notes Offering

MT Newswires Live
·
26 Feb